P5R-25760-62502
3 vaccinations
5 coded responses
38 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 275 / NC
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
-
2021-04-14
Survey response — day 14, dose 1MedDRA: Dysphonia, Oropharyngeal pain, Seasonal allergy — Feeling: GoodFree text: Hay fever for a few days and sore throat 1 day and hoarse voice 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-06-30
Survey response — 3 months, dose 1MedDRA: Diarrhoea, Gastroenteritis viral, Nasopharyngitis, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach flu (diarrhea, vomiting) for 2 days; cold symptoms for 5 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-29
-
2021-12-02
Dose 2 — Moderna
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-16
- 2021-12-23
-
2021-12-30
Survey response — day 28, dose 2MedDRA: Cough, Nasal congestion, Nasopharyngitis, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold symptoms- stuffy nose, sneezing, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-01-06
- 2022-01-13
- 2022-03-03
- 2022-06-02
-
2022-09-26
Dose 3 — ModernaCo-administered: Flu
- 2022-10-05
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-11-02
- 2022-11-07
-
2022-12-26
Survey response — 3 months, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Congestion, cough (both mild)MedDRA releases: 2024-11 · check-in free text available
-
2023-03-27
Survey response — 6 months, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-02 | Moderna | No |
| 3 | 2022-09-26 | Moderna | Flu |
Free text
Release 7 — day 14, dose 1
Symptoms: Hay fever for a few days and sore throat 1 day and hoarse voice 2 days
Release 9 — 3 months, dose 1
Symptoms: Stomach flu (diarrhea, vomiting) for 2 days; cold symptoms for 5 days
Release 10 — day 28, dose 2
Symptoms: Cold symptoms- stuffy nose, sneezing, cough
Release 12 — 3 months, dose 3
Symptoms: Congestion, cough (both mild)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Seasonal allergy | ✓ | ✓ | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release